Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Update
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Resultson Monday December 16, 2019
Anavex Life Sciences Presents ANAVEX®2-73 Data at 12th Clinical Trials on CTAD 2019 Conference
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Study Updates
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, 8/7/2019
Anavex Life Sciences Reports Fiscal 2019 Second Quarter Financial Results, Updates on Clinical Study
Anavex Life Sciences to Announce Fiscal 2019 Second Quarter Financial Results on Wednesday, 5/8/2019
Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Anavex Life Sciences Presents Data On ANAVEX®2-73 in Alzheimer’s Disease at the ASENT 2019 Meeting
Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019
Anavex Life Sciences to Present at the Cowen 39th Annual Health Care Conference 2019
Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results & Updates on Clinical Study
Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference
Anavex Life Sciences to Announce Fiscal 2019 First Quarter Financial Results on Thursday, 2/7/2019
Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, 12/12/2018
Follow us on social media
